Sinclair at IMCAS 2025: A comprehensive approach to aesthetic medicine

IMCAS World Congress 2025

The IMCAS World Congress 2025 in Paris marked another milestone in aesthetic medicine, drawing a record-breaking 20,000 attendees over three days. Alongside a packed scientific agenda, Sinclair showcased its commitment to innovation, education, and interactive learning through a series of highly attended sessions and experiences. This also included participation in the renowned IMCAS Cadaver Workshop, where Dr Massimo Gianfermi highlighted the benefits of Lanluma for body indications*, offering invaluable insights into collagen stimulation for body contouring.

Sinclair Symposium

The flagship Sinclair Symposium saw an incredible turnout, with over 800 delegates filling Amphitheatre Bleu for an immersive two-hour session. Featuring live demonstrations of Sinclair’s leading collagen stimulators and HA range, the symposium provided a deep dive into tailored treatment journeys. Featuring live demonstrations with Ellansé, Sinclair’s PCL-based immediate volumising collagen stimulator and Lanluma its PLLA-based gradual collagen stimulator and MaiLi, its premium HA filler—demonstrating their role in patient-specific aesthetic treatment plans. Led by an esteemed panel of Key Opinion Leaders—including Dr Francisco De Melo, Dr Florent Bonnet, Dr Kristina Davidovic, Dr Francesca De Angelis, Dr. Kyungkook Hong, Dr Shang-li Lin, Dr Ingrid López-Gehrke, Dr Peter Palhazi, and Dr Franco Vercesi—the session seamlessly blended anatomy-based learning, ultrasound-guided assessment, and live treatment demonstrations.

Reflecting on the event, Dr Francisco De Melo shared his thoughts:

"IMCAS 2025 brought together experts from around the world to share insights and research in aesthetics. The Sinclair Symposium provided a unique opportunity to explore tailored treatment journeys, designed to meet the needs of diverse patient demographics. With a comprehensive approach that integrates anatomy-based learning, patient assessment, and live demonstrations, it was a pleasure to be part of such an engaging session. I look forward to continuing these discussions at future Sinclair events in 2025."

Meet the Expert

Beyond the symposium, Sinclair extended its educational outreach with eight Meet the Expert sessions at its booth. These sessions were led by industry experts and Sinclair KOLs, including members of the RISE Alumni, providing delegates with the opportunity to engage in discussion-led learning with top physicians.

Delegates also had the opportunity to delve into the research and innovation behind Sinclair’s products by visiting the immersive Innovation Lab. Scientists responsible for the development of Sinclair’s cutting-edge technologies demonstrated the unique properties of Ellansé, MaiLi, and Lanluma, providing attendees with deeper scientific insights into, Primelase, V-SERIES and Sculpt&Shape. Through interactive learning and hands-on experiments, delegates explored the advanced science underpinning Sinclair’s product portfolio, gaining a deeper understanding of the mechanisms and benefits of collagen stimulation and HA-based treatments. Over 570 delegates participated in these sessions, which also featured bespoke anatomy lectures to further reinforce the principles of aesthetic assessment and precision treatment planning.

CEO Amber Edwards

Another key moment of the congress was CEO Amber Edwards’ participation in La Tribune, where she joined other industry leaders to discuss the evolving aesthetic market landscape. She addressed the growing demand for natural-looking results while maintaining efficacy and shared her vision for the future of the industry.

"I truly believe that this category is desperate for real disruption, and I see an incredible intersection happening right now. Traditional aesthetics—fillers, toxins, lasers—are converging with longevity, beauty, wellness, and feminine health. A menopause revolution is underway, and all of these elements are coming together. Where I want to take Sinclair is to become the first truly holistic aesthetics company, supporting women throughout their entire aesthetic journey." - Amber Edwards, Sinclair CEO

As Sinclair looks ahead, the company remains dedicated to shaping the future of aesthetic medicine through education, innovation, and collaboration. Thank you to all who joined Sinclair at IMCAS 2025—the company looks forward to welcoming delegates to upcoming events throughout the year.

* Due to country specifics, the contents of this presentation and demonstration and any other communication relating to the product Lanluma are not intended for and are not relevant for healthcare practitioners based in all countries, in particular not those based in Germany. This in particular relates to the contents on the usage of Lanluma in body areas other than the face.

Want to learn more? Contact the Sinclair team today